Gibson, Dunn & Crutcher LLP Advised Biosynth Carbosynth in its Acquisition of Aalto Bio Reagents

June 7, 2022

Gibson, Dunn & Crutcher LLP advised Biosynth Carbosynth, a portfolio company of the KKR Health Care Growth, in its acquisition of Aalto Bio Reagents. More information can be found in the news announcement.

The Gibson Dunn team was led by partner Wim De Vlieger and included partner Till LeFranc and associates Jakob Egle, Bansaree Shah, Ciaran Deeny, Romain Tourenne and Levi Marelus. Partner Sandy Bhogal and associate Bridget English advised on tax aspects. Partner Ahmed Baladi and associate Clémence Pugnet advised on data protection aspects. Partner Michael Walther, of counsels Richard Roeder and Christopher Timura and associates Linda Vogele and Chris Mullen advised on regulatory aspects.